FRANKLIN LAKES, N.J., July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to a U.S.

Hospitals across the country are facing a severe shortage of supplies of blood culture bottles, critical tools for diagnosing serious and sometimes life-threatening bloodstream infections. The Centers ...

The CDC released an updated advisory to healthcare providers on July 22 regarding the BD BACTEC blood culture bottle shortage. The update highlights the potential for delay in patient diagnosis along ...

Medical device company Becton Dickinson (BD) may be nearing the end of a shortage of plastic bottles used to contain blood culture media, a company official said Tuesday. "Because of actions BD ...

Please provide your email address to receive an email when new articles are posted on . The U.S. experiences a shortage of blood culture bottles in July 2024. Affected facilities here were fewer ...

BD is seeing a shortage of its blood culture vials used to support a wide array of infectious disease diagnostics, and the FDA is urging healthcare providers to ration their current supplies and ...

The FDA sent a letter to healthcare providers July 10 regarding the shortage, and the CDC released updated conservation strategies in a July 22 statement. The FDA estimates the shortage will continue ...

The U.S. Centers for Disease Control and Prevention has issued a health advisory on a shortage of plastic Becton Dickinson and Co. Bactec blood culture media bottles, made by a singular supplier. CDC ...

The Centers for Disease Control and Prevention issued a Health Alert Network advisory on July 23 about a critical Becton Dickenson blood culture vial shortage that will seriously disrupt patient care.

On July 10, the FDA issued an advisory to clinicians that Becton Dickinson (BD) had announced a global shortage of their Bactec blood culture bottles -- which are essential in the case of suspected ...

Achieves a ~3‑hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy. First‑of‑its‑kind blood volume measurement ...